A new study reveals that recovery from anti-NMDAR encephalitis, popularized as “brain on fire” disorder, can take three years or longer, with many patients experiencing lasting cognitive and social challenges.
Published in Neurology | Estimated reading time: 6 minutes
Recovery from one of the most severe forms of brain inflammation takes significantly longer than previously believed, according to research from Erasmus University Medical Center in the Netherlands. The study followed 92 patients with anti-NMDAR encephalitis, finding that while initial improvements occur rapidly in the first six months, full recovery can extend beyond three years.
The condition, which primarily affects young adults, begins with seemingly mild symptoms – headache, fatigue, and fever. However, it can rapidly progress to serious neurological issues including confusion, memory loss, behavioral changes, disordered thinking, hallucinations, and even seizures. Due to its complex presentation, it’s sometimes misdiagnosed as schizophrenia or bipolar disorder.
“While more than 80% of people treated for anti-NMDAR encephalitis return to living independently after one to two years, most report continued thinking and memory problems as well as social difficulties,” explained study author Maarten Titulaer, MD, PhD, of Erasmus University Medical Center.
The research team conducted comprehensive assessments of patients diagnosed before 2023, including physical examinations, neuropsychological testing, and detailed medical record reviews. Of the 92 participants, with an average age of 29, 85 underwent specific cognitive testing examining memory, language, attention, and executive function.
The findings paint a complex picture of recovery. While patients showed the most rapid improvements in the first six months following diagnosis, they continued to make slower progress for up to three years. However, even after this extended period, many participants faced ongoing challenges. Among those assessed beyond the three-year mark, 34% showed continued impairment, and 65% scored below average in at least one cognitive area, with memory and language being particularly affected.
The impact on patients’ daily lives proved significant. Nearly one-third (30%) were unable to return to their previous work or educational pursuits, while 18% required specific accommodations to resume these activities. Those who successfully returned to work or school typically demonstrated better scores in both general well-being and processing speed – a crucial cognitive function that determines how quickly the brain can receive and respond to information.
“Identifying subtle cognitive, social or emotional symptoms is imperative,” Titulaer emphasized, “especially since this disease primarily affects young adults. The impact on their school, work and social life can be immense.”
While the study provides valuable insights into the recovery trajectory, researchers note some limitations. The study focused on less severe cases, excluding children under 16 and those who did not survive the condition. This suggests that the full spectrum of recovery patterns might be even more complex than documented.
These findings underscore the need for extended support systems and ongoing monitoring of patients well beyond the initial recovery period, particularly given the condition’s impact on young adults during critical educational and career development periods.
Glossary
- Anti-NMDAR encephalitis
- An autoimmune condition where the body’s immune system attacks brain receptors, causing inflammation and neurological symptoms.
- Executive function
- Mental skills that help with planning, focusing attention, remembering instructions, and juggling multiple tasks.
- Processing speed
- How quickly the brain can receive, understand and respond to information.
- Immunotherapy
- Treatment that uses the body’s immune system to fight disease, or in this case, to suppress harmful immune responses.
Test Your Knowledge
How long can full recovery from anti-NMDAR encephalitis take?
Three years or longer, with some patients experiencing lasting effects even after this period.
What percentage of patients showed continued impairment after three years?
34% of study participants demonstrated ongoing impairment.
What are the initial symptoms of the condition?
Headache, fatigue, and fever, before progressing to more serious neurological symptoms.
When do patients show the most rapid improvement?
In the first six months after diagnosis, followed by slower improvements up to three years.
Enjoy this story? Subscribe to our newsletter at scienceblog.substack.com
